BACKGROUND: Methylation of the CpG islands in the p16 gene promoter region is an important transcription repression mechanism that has been identified as an alternative mechanism for inactivating specific genes in cancer. Given that, DNA methylation is a common event in colorectal cancer. MATERIALS AND METHODS: The aim of this study was to establish the methylation status of the p16 gene in 104 patients with colorectal carcinoma and evaluate its prognostic value. DNA was bisulfite-modified and analyzed for p16 promoter methylation by methylation-specific PCR. RESULTS: Methylation of thep16 gene was determined in 18.3% of our patient population (19/104). The methylated state did not correlate with any clinicopathological factors. During a median follow-up period of 72 months, the overall survival rate for patients with gene methylation was 75% and without gene methylation it was 61% (p = 0.09). CONCLUSIONS: Although not statistically significant, this difference indicates a clinically valuable tendency. Copyright 2005 S. Karger AG, Basel.
BACKGROUND: Methylation of the CpG islands in the p16 gene promoter region is an important transcription repression mechanism that has been identified as an alternative mechanism for inactivating specific genes in cancer. Given that, DNA methylation is a common event in colorectal cancer. MATERIALS AND METHODS: The aim of this study was to establish the methylation status of the p16 gene in 104 patients with colorectal carcinoma and evaluate its prognostic value. DNA was bisulfite-modified and analyzed for p16 promoter methylation by methylation-specific PCR. RESULTS: Methylation of thep16 gene was determined in 18.3% of our patient population (19/104). The methylated state did not correlate with any clinicopathological factors. During a median follow-up period of 72 months, the overall survival rate for patients with gene methylation was 75% and without gene methylation it was 61% (p = 0.09). CONCLUSIONS: Although not statistically significant, this difference indicates a clinically valuable tendency. Copyright 2005 S. Karger AG, Basel.
Authors: Kaori Shima; Katsuhiko Nosho; Yoshifumi Baba; Mami Cantor; Jeffrey A Meyerhardt; Edward L Giovannucci; Charles S Fuchs; Shuji Ogino Journal: Int J Cancer Date: 2011-03-01 Impact factor: 7.396
Authors: S Veganzones; M L Maestro; S Rafael; V de la Orden; M Vidaurreta; B Mediero; M Espantaleón; J Cerdán; E Díaz-Rubio Journal: Tumour Biol Date: 2015-01-10
Authors: Medha Sugara; Ramachandra Chowdappa; K V Veerendra Kumar; Ramesh Gawari; Shalini N Swamy; Sandeep S Kumar Journal: Indian J Surg Oncol Date: 2021-04-24
Authors: Muriel X G Draht; Danny Goudkade; Alexander Koch; Heike I Grabsch; Matty P Weijenberg; Manon van Engeland; Veerle Melotte; Kim M Smits Journal: Clin Epigenetics Date: 2018-03-14 Impact factor: 6.551
Authors: Fabiana Greyce Oliveira Almeida; Priscila Ferreira de Aquino; Afonso Duarte Leão de Souza; Antonia Queiroz Lima de Souza; Sonia do Carmo Vinhote; Thaís Messias Mac-Cormick; Marcelo Soares da Mota Silva; Sidney Raimundo Silva Chalub; Juliana de Saldanha da Gama Fischer; Paulo Costa Carvalho; Maria da Gloria da Costa Carvalho Journal: Biol Res Date: 2015-09-12 Impact factor: 5.612